Podcasts about Prostate cancer

Topics discussed on today's show: Frank's Root Canal, Smelly Celeb, Peanuts Gang, Sports News, Science News, Birthdays, Mean Girls Day, History Quiz, Musicians and Pain, Glue Bones, Cosmic Illusion, Peacocks, Jane Goodall, Music News, Sleeping in a Sellers Home, National BF Day, Single Lisa, SOG: Mama No Likey, Spotify AI, Prostate Cancer, Shark Bites, People with Rabies, Probably White?, and Apologies.

1 out of 8 men will get prostate cancer, which means 7 of you are in the clear. I found out I have it in early June and tomorrow I'm having a radical prostatecomy... removal of the prostate. By the time many of y'all hear this, I'll be cancer-free. The procedure is farily routine, my friends and family are here for me and I live a charmed life. I'm relatively young, healthy with excellent health insurance. And let's not forget I'm devilishly handsome. Catching this early afforded me so many options to eradicate the cancer.  I'm using this episode as a call to action for you men to get your PSA levels checked! More filmmaking talk next week! FILMMAKER RETREAT JOSHUA TREE '26 - SAVE YOUR SPOT! Thursday, October 1st – Sunday, October 4th, 2026. Limit 15 Filmmakers. This will be our 5th year. Limit 15 filmmakers and only 14 spots remain so SIGN UP! ONLINE FILMMAKING COURSES - DIRECT WITH CONFIDENCEEach of my online courses come with a free 1:1 mentorship call with yours truly. Taking the Shadow course is the only way to win a chance to shadow me on a real shoot! DM for details. Want to level up your commercial directing game? MAGIC MIND - MY MENTAL PERFORMANCE EXILIR - SAVE w BRADY20Save hugely on Magic Mind with this link. — This link is the way.  TRIPPY Check out Frequency Caps to try some mushroom-based treats. I like the cocao cubes. The code is BRADY10. Also, if you're in LA, Frequency House hold ceremonies often. Thanks, Jordan My cult classic mockumentary, "Dill Scallion" is online so I'm giving 100% of the money to St. Jude Children's Hospital. I've decided to donate the LIFETIME earnings every December, so the donation will grow and grow annually. Thank you. "Respect The Process" podcast is brought to you by Commercial Directing FIlm School and True Gent, aka True Gentleman Industries, Inc. in partnership with Brady Oil Entertainment, Inc.

Did you know that Prostate Cancer is one of the most common cancers among men?  It is also the second leading cause of cancer death in men, behind only lung cancer. To raise awareness and learn more about prostate cancer, I had the pleasure to sit down with Dr. David Hepps of St. Clair Medical Group Urology. In this episode, we discuss practical steps men can take for early detection and better outcomes, as well as how St. Clair supports patients and families through collaborative care and quality-of-life considerations. We also review treatment options such as robotic surgery, active surveillance, and the BioProtect Balloon that helps protect healthy tissue during radiation treatment.  To  schedule an appointment with Dr. Hepps or another St. Clair Medical Group Urology provider, call 412-942-4100.   Thank you St. Clair Health for sponsoring this episode. To learn more about St. Clair Health,  visit https://www.stclair.org/ All episodes are available on Youtube at http://www.youtube.com/@Spillwithmejennyd as well as all the major audio platforms. Interested in being a guest or sponsor on Spill with Me Jenny D Show? Contact Kelli Komondor at kelli@k2creativellc.com To view previous episodes and fill out a disclaimer to be a guest Under Tell us Your Story visit...https://www.spillwithmejennyd.com/

Thabo shole-Mashao standing in for Clement Manyathela speaks with Andrew Oberholzer, CEO of the Prostate Cancer Foundation, to discuss the critical importance of prostate cancer screening, awareness, and proactive health management. The Clement Manyathela Show is broadcast on 702, a Johannesburg based talk radio station, weekdays from 09:00 to 12:00 (SA Time). Clement Manyathela starts his show each weekday on 702 at 9 am taking your calls and voice notes on his Open Line. In the second hour of his show, he unpacks, explains, and makes sense of the news of the day. Clement has several features in his third hour from 11 am that provide you with information to help and guide you through your daily life. As your morning friend, he tackles the serious as well as the light-hearted, on your behalf. Thank you for listening to a podcast from The Clement Manyathela Show. Listen live on Primedia+ weekdays from 09:00 and 12:00 (SA Time) to The Clement Manyathela Show broadcast on 702 https://buff.ly/gk3y0Kj For more from the show go to https://buff.ly/XijPLtJ or find all the catch-up podcasts here https://buff.ly/p0gWuPE Subscribe to the 702 Daily and Weekly Newsletters https://buff.ly/v5mfetc Follow us on social media: 702 on Facebook https://www.facebook.com/TalkRadio702 702 on TikTok https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/Radio702 702 on YouTube: https://www.youtube.com/@radio702 See omnystudio.com/listener for privacy information.

Should men with prostate cancer get vaccinated? Every health decision feels weightier during treatment—including vaccines. In this episode, Dr. Stephen Petteruti takes an evidence-based look at vaccines during prostate cancer treatment, examining how common shots: COVID, flu, tetanus, pneumococcal, hepatitis, and shingles, affect the immune system when it's already under pressure.He explores which vaccines may strengthen the immune system, which may create unnecessary risks, and how these choices fit into a personalized plan for living well with prostate cancer.This episode is designed to empower men with knowledge, so they can make decisions with confidence and keep their focus on living stronger, longer. Tune in now: Should You Get Vaccines During Prostate Cancer Treatment? Enjoy the podcast? Subscribe and leave a 5-star review.Dr. Stephen Petteruti is a leading Functional Medicine Physician dedicated to enhancing vitality by addressing health at a cellular level. Combining the best of conventional medicine with advancements in cellular biology, he offers a patient-centered approach through his practice, Intellectual Medicine 120. A seasoned speaker and educator, he has lectured at prestigious conferences like A4M and ACAM, sharing his expertise on anti-aging. His innovative methods include concierge medicine and non-invasive anti-aging treatments, empowering patients to live longer, healthier lives.Website: www.intellectualmedicine.com Website: https://www.theprostateprotocol.com/ YouTube: https://www.youtube.com/@intellectualmedicine LinkedIn: https://www.linkedin.com/in/drstephenpetteruti/ Instagram: instagram.com/intellectualmedine Consultation: https://www.theprostateprotocol.com/book-a-consultation Store: https://www.theprostateprotocol.com/store Community: https://www.theprostateprotocol.com/products/communities/v2/fightcancerlikeaman/home    Disclaimer:  The content presented in this video reflects the opinions and clinical experience of Dr. Stephen Petteruti and is intended for informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional diagnosis, treatment, or guidance from your personal healthcare provider. Always consult your physician or qualified healthcare professional before making any changes to your health regimen or treatment plan.Produced by https://www.BroadcastYourAuthority.com 

Prostate cancer is the leading cause of cancer deaths among men in Kenya, claiming an estimated five lives each day. Despite the alarming toll, conversations on screening and early detection remain shrouded in stigma. DW's Eddy Micah Jr. explores the issue with correspondent Felix Maringa in Kenya and medical expert Dr. Martin Kuria.

Prostate cancer affects 1 in 8 white men and 1 in 4 black men, killing 12,000 every year – yet it remains the most common cancer without a national screening programme.So today we were raising awareness for prostate cancer.I wanted to find out what the signs are and share why it's so important we're aware of it!We were joined by Errol McKellar NBE and Chris Powell NBE to hear why it's so important that we all understand what Prostate Cancer is and why you should get checked!Plus, there's the pub lunch quiz for your chance to grab yourself 6 points, and you'll hear all the best messages we received.Want to learn more about prostate cancer? Check out these sources:Errol McKellar Foundation - https://www.theerrolmckellarfoundation.com/Prostate Cancer UK - https://prostatecanceruk.orgCatch Clive On Fix Radio Monday - Thursday 12 PM - 3 PM Across The UK On DAB Radio And Online At https://www.fixradio.co.uk/ 

(00:00) Zolak & Bertrand are joined by RJ Bell of Pregame.com to discuss the best bets for Week 4 of the NFL season.(11:00) Patriots HC Mike Vrabel announces that DC Terrell Williams has been diagnosed with prostate cancer.(23:00)The crew finishes up the day by hitting on a bunch of different Patriots thoughts. (34:23) We close out the show with the takeaways from today.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Prostate cancer is common- unfortunately even more common and often deadlier in Black men. Meet a patient who learned he didn't need treatment right away and how his team at The University of Kansas Cancer Center helped make the decision on when to have surgery.

In part 1 of this episode, Mr Rick Dunn talks about his experience dealing with Prostate Cancer. With September being Prostate Awareness Month, we talk about the importance of getting checked for Prostate cancer. Black Men are run a higher risk of getting Prostate Cancer, but if you have a family history of the cancer, early detection is the key to surviving.

Dr. Lindsay Hampson discusses urinary incontinence and sexual dysfunction following prostate cancer treatment, emphasizing that both are common and treatable. She explains the different types of incontinence—stress, urge, mixed, and overflow—and outlines how understanding the cause helps guide treatment. Options include pelvic floor physical therapy, medications, surgical interventions like slings or artificial sphincters, and supportive devices. Dr. Hampson also reviews effective strategies for managing erectile dysfunction, such as oral medications, vacuum devices, injections, and penile implants. She highlights the importance of shared decision-making and reassures patients that even small symptoms can significantly affect quality of life and deserve attention. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40814]

Dr. Lindsay Hampson discusses urinary incontinence and sexual dysfunction following prostate cancer treatment, emphasizing that both are common and treatable. She explains the different types of incontinence—stress, urge, mixed, and overflow—and outlines how understanding the cause helps guide treatment. Options include pelvic floor physical therapy, medications, surgical interventions like slings or artificial sphincters, and supportive devices. Dr. Hampson also reviews effective strategies for managing erectile dysfunction, such as oral medications, vacuum devices, injections, and penile implants. She highlights the importance of shared decision-making and reassures patients that even small symptoms can significantly affect quality of life and deserve attention. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40814]

Dr. Lindsay Hampson discusses urinary incontinence and sexual dysfunction following prostate cancer treatment, emphasizing that both are common and treatable. She explains the different types of incontinence—stress, urge, mixed, and overflow—and outlines how understanding the cause helps guide treatment. Options include pelvic floor physical therapy, medications, surgical interventions like slings or artificial sphincters, and supportive devices. Dr. Hampson also reviews effective strategies for managing erectile dysfunction, such as oral medications, vacuum devices, injections, and penile implants. She highlights the importance of shared decision-making and reassures patients that even small symptoms can significantly affect quality of life and deserve attention. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40814]

Dr. Lindsay Hampson discusses urinary incontinence and sexual dysfunction following prostate cancer treatment, emphasizing that both are common and treatable. She explains the different types of incontinence—stress, urge, mixed, and overflow—and outlines how understanding the cause helps guide treatment. Options include pelvic floor physical therapy, medications, surgical interventions like slings or artificial sphincters, and supportive devices. Dr. Hampson also reviews effective strategies for managing erectile dysfunction, such as oral medications, vacuum devices, injections, and penile implants. She highlights the importance of shared decision-making and reassures patients that even small symptoms can significantly affect quality of life and deserve attention. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40814]

Prostate cancer deaths have been climbing over the last decade in part due to confusion over who should be screened and treated. In part 1 of a three-part series on prostate cancer, host Sandra Lindsay speaks with Samir Taneja, MD, a trailblazer in urologic cancer innovation, to explore how modern diagnostics and treatments, such as the groundbreaking use of MRI technology, are transforming patient outcomes. As Northwell's senior vice president and system chair of urology, Dr. Taneja provides invaluable insights into the shifting landscape of prostate cancer care and the critical importance of early detection. Tune in to understand the vital steps needed to increase awareness and save lives. About Northwell Health Northwell Health is New York State's largest healthcare provider and private employer, with 21 hospitals, 850 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities. Get more expert insights from leading experts in the field — Northwell Newsroom.  Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Interested in a career at Northwell Health? Visit the health system's job portal and explore our many opportunities.    

On this episode host Jonathan Chance talks with renowned Uro-oncologist Dr. Grgur Miric about the health benefits of exercise, especially if you are diagnosed with a disease like prostate cancer. On this episode Jonathan and Dr. Miric talk about:·       How exercise is good for fighting prostate cancer and other diseases. ·       Studies that support fighting disease through exercise·       Why early detection is so important when it comes to prostate cancer.·       Who is at greater risk for a prostate cancer diagnosis.Prostate Cancer Aware is grateful to the Jevan and Ruzanna Chimayan Foundation for their generous donation, which will help fuel our podcast to raise critical awareness about prostate cancer and the PSA test around the world.Prostate Cancer Aware is a copyrighted production. No content maybe rebroadcast or reproduced without the expressed written consent of the Friedman Sidrow Foundation. For more information about prostate cancer, the PSA test, men's health and Jonathan's inspiring new book Unaware, which is about his battle with prostate cancer. Visit our website at: https://www.iknowmypsa.org Email us at: https://www.iknowmypsa.org/contactus/ Follow Prostate Cancer Aware on social media at: Facebook - https://www.facebook.com/iknowmypsa Twitter - https://twitter.com/iknowmypsa or @iknowmypsa Thank you for listening! Remember, Stay Aware and Stay Healthy.™

In this heartfelt episode, I sit down with David and Veronica a husband and wife who bravely share their journey through prostate cancer. He opens up about the difficult decision to undergo surgery, the emotions that came with it, and the grief he and his wife faced together. She shares how her unwavering support became a source of strength, reminding us that love and partnership can be a powerful medicine.Their story is not just about illness, it's about resilience, vulnerability, and the courage to face life's hardest moments side by side. It's also a call to action for men everywhere: take your health seriously, get your prostate checked, and don't be afraid to lean on those who love you.Tune in to hear a raw, emotional conversation about love, grief, and healing in the face of prostate cancer.

On this episode of The Mark White Show, we shine a spotlight on prostate cancer, the second most common cancer among men. Dr. Benjamin Lowentritt, Director of Prostate Cancer Services at United Urology Group and a nationally recognized leader in advanced treatments, explains the importance of early detection, current treatment options, and promising new research. Prostate cancer survivor Bob Lane then shares his personal journey and how he now encourages other men through the SHARE Network. Together, they bring both the medical expertise and human perspective needed to inspire awareness, action, and hope for men and their families.

The Marie Keating Foundation is trying to raise awareness around prostate cancer, including how you now only need to take a blood test to check for it - “no bum hole needed”!To discuss further, Seán is joined by Henry McKean.

Prostate cancer is one of the most urgent health issues facing men in Pennsylvania, according to cancer advocates and survivors who are working to remove barriers to early detection.Support WITF: https://www.witf.org/support/give-now/See omnystudio.com/listener for privacy information.

On this Make A Difference Minute, I'm joined by Bob Lane, a prostate cancer survivor and patient advocate. When Bob was diagnosed, he faced the fear and uncertainty that so many men feel, but he chose to take action with the support of his doctors, family, and community. Today, he shares his story through the SHARE Network to encourage other men not to ignore their health. Bob's message is clear: get checked, listen to your body, and don't wait until it's too late. His journey shows that early detection and treatment can make all the difference, and that no one has to face prostate cancer alone. Sponsor: Thompson Roofing & Construction 256roofing.com

Radiologist Dr. Julian Hong plains how stereotactic body radiation therapy (SBRT) is used to treat oligometastatic prostate cancer—cases where cancer has spread but only to a few limited sites. This approach targets small clusters of metastases with high-dose, image-guided radiation in five or fewer sessions. Hong reviews clinical trial evidence showing that adding focal radiation can improve outcomes, especially when all visible metastases are treated. He highlights the value of modern imaging, like PET scans, in identifying lesions and shaping personalized treatment plans. Studies suggest SBRT offers effective disease control with low toxicity and minimal impact on quality of life, making it a promising option for patients with limited metastatic spread. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40807]

Radiologist Dr. Julian Hong plains how stereotactic body radiation therapy (SBRT) is used to treat oligometastatic prostate cancer—cases where cancer has spread but only to a few limited sites. This approach targets small clusters of metastases with high-dose, image-guided radiation in five or fewer sessions. Hong reviews clinical trial evidence showing that adding focal radiation can improve outcomes, especially when all visible metastases are treated. He highlights the value of modern imaging, like PET scans, in identifying lesions and shaping personalized treatment plans. Studies suggest SBRT offers effective disease control with low toxicity and minimal impact on quality of life, making it a promising option for patients with limited metastatic spread. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40807]

Radiologist Dr. Julian Hong plains how stereotactic body radiation therapy (SBRT) is used to treat oligometastatic prostate cancer—cases where cancer has spread but only to a few limited sites. This approach targets small clusters of metastases with high-dose, image-guided radiation in five or fewer sessions. Hong reviews clinical trial evidence showing that adding focal radiation can improve outcomes, especially when all visible metastases are treated. He highlights the value of modern imaging, like PET scans, in identifying lesions and shaping personalized treatment plans. Studies suggest SBRT offers effective disease control with low toxicity and minimal impact on quality of life, making it a promising option for patients with limited metastatic spread. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40807]

Radiologist Dr. Julian Hong plains how stereotactic body radiation therapy (SBRT) is used to treat oligometastatic prostate cancer—cases where cancer has spread but only to a few limited sites. This approach targets small clusters of metastases with high-dose, image-guided radiation in five or fewer sessions. Hong reviews clinical trial evidence showing that adding focal radiation can improve outcomes, especially when all visible metastases are treated. He highlights the value of modern imaging, like PET scans, in identifying lesions and shaping personalized treatment plans. Studies suggest SBRT offers effective disease control with low toxicity and minimal impact on quality of life, making it a promising option for patients with limited metastatic spread. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40807]

Its Blue September – New Zealand's Prostate Cancer Awareness month. We've talked about it in the past, however it's good to remind all the men out there of the importance of the prostate. Why is Blue September important? It's a campaign promoting awareness around prostate cancer. Raises money for Prostate Cancer Foundation. Its key focus is to make you think about prostate cancer and talk about it with your GP. Some key reasons to think about prostate cancer: 4000 men are diagnosed per year – it's the most common cancer for men in New Zealand. 1 in 8 men will develop it over a lifetime. More than 600 men die from prostate cancer each year. Early detection often means early treatment. Most cases occur to those over the age of 60. What does the prostate do and what do we need to look out for? The prostate is the size of a walnut and sits at the outlet to the bladder. It produces fluid for sperm. Naturally increases in size as get older, which is normal. However, cancer can sometimes develop inside the prostate. If it enlarges, the prostate can block the entrance to bladder casing, which can result in: Passing urine a lot. Getting up at night to pass urine. Feeling the sudden need to go to the toilet. A weak urine stream Any symptoms or change in passing urine, you need to see your GP for check-up. It often involves a prostate blood test (PSA), sometimes a rectal exam, and maybe a urine check. High PSA can indicate the need for further tests to exclude prostate cancer. Should we get a regular prostate check if we have no symptoms? From the age of 50 it is something you should discuss with your GP. There is no national screening program so it is an individual decision – many men will choose to have a blood test from the age of 50. Presently there is no firm evidence that a national screening program saves lives. However, a big study is happening in Europe to see if it should be done. Many doctors do recommend check-ups from the age of 50. If you are concerned or reached the age of 50, please discuss a prostate check with your GP. LISTEN ABOVE See omnystudio.com/listener for privacy information.

Sean Hawley is back on Trap Talk for the 6th time—and he never disappoints!

In this episode, host Chris Duffin sits down with the legendary Clark Bartram—Marine veteran, National Fitness Hall of Fame inductee, and founder of the Maximized Man Elite program. Known as America's most trusted fitness professional, Clark has dedicated his life to inspiring men to reclaim their vitality, strength, and purpose—naturally and sustainably. Clark Bartram's journey in men's health and fitness is nothing short of remarkable. Once a U.S. Marine, Clark transformed his discipline and passion into a decades-spanning career—earning recognition as “America's most trusted fitness professional.” He's inspired millions through books, TV appearances, and elite coaching, notably with his Maximized Man Elite program, guiding men over 40 to reclaim vitality and strength naturally. At age 61, Clark faced a new test: a diagnosis of prostate cancer despite his peak condition. Rather than let it stop him, Clark became an advocate, founding the nonprofit “Check It Like a Man” to promote early screening and awareness. Clark Bartram: https://clarkbartramsystems.com Instagram: @clarkbartram   This episode of the ARCHITECT of RESILIENCE podcast is available on Apple, Spotify & YouTube, and is sponsored by: @marekhealth : Performance. Longevity. Optimization.

About 1 in 8 men will face a prostate cancer diagnosis. Early-stage prostate cancer often has no symptoms—so how should men approach screening and advocacy? What disparities do Black men experience that would negatively impact their outcomes? And what can we do about it? We spoke with Otis Brawley, MD, professor of oncology at Johns Hopkins, about the types of prostate cancer, key symptoms, when and how often to screen, and why access to equal treatment is essential for equal outcomes for Black men. He also explains metastatic castration-resistant prostate cancer and why advanced imaging like PSMA PET scans matters. Survivor David Diaz Sr., executive director of The Reluctant Brotherhood, also shares his story of diagnosis, treatment, and the power of support groups for men navigating prostate cancer. See omnystudio.com/listener for privacy information.

Dr Bill Nelson talks to Dr Catherine Handy Marshall about the broader range or treatments available for advanced prostate cancer at the Johns Hopkins Kimmel Cancer Center that are leading to better outcomes, fewer side-effects and longer survival.

HR1 Signs Your Child Isn't Getting Enough Sleep. Prostate Cancer Isn't Just for Grandpa. 9-17-25 by John Rush

What if prostate cancer surgery meant fewer incisions, faster recovery, and more precise cancer control? Today I'm joined by Dr. Michael D. Stifelman, Chair of Urology at Hackensack University Medical Center and a pioneer in robotic surgery with 4,000+ robotic procedures. We unpack how single-port robotics, real-time margin assessment, and AI are reshaping outcomes—while protecting continence and erections.Dr. Stifelman traces robotics from the early-2000s “pioneer phase” (and heavy skepticism) to today's standard of care, explaining why reproducibility, visualization, and tissue-sparing dexterity made the difference. We compare surgery vs. radiation (and focal therapies), when each shines, and why sequencing often matters—especially in higher-risk disease. He shares emerging tech like single-port prostatectomy, intra-operative margin evaluation (e.g., Histo-style scanning), quantitative surgical analytics, and even remote robotic assistance. We also talk “trifecta” outcomes, the role of genomics in Gleason 7 decision-making, and why lifestyle medicine and optimizing the tumor micro-environment go hand-in-hand with any treatment.Time-Stamped Highlights00:00 – Why fewer incisions + faster recovery are now real in prostate surgery05:40 – Work–life changes that improved health (sleep, exercise, biking)09:10 – Open vs. robotic: why reproducibility (teachability) matters11:05 – Robotics adoption curve: from early resistance to mainstream19:05 – Outcomes today: continence and erections after modern surgery20:10 – “Yes, I'm a surgeon—and here's my bias.” Radical honesty with patients22:05 – Offering the full menu: surveillance, focal (HIFU/cryotherapy), surgery, SBRT, proton25:40 – High-risk (Gleason 8–9): why surgery-first can preserve options & avoid long ADT34:00 – Dexterity & visualization: why robots spare nerves with less trauma35:10 – Real-time margin assessment during surgery to reduce positives40:00 – The “trifecta” (cancer control, continence, erections) and patient priorities42:10 – Genomics to risk-stratify Gleason 7 and guide surveillance vs. treatment45:00 – Future: nerve activation mapping & fluorescence to “light up” cancer46:10 – Single-port prostatectomy: smaller access, faster return of function (select patients)49:00 – Quantifying surgery with analytics; tele-mentoring & remote console potential52:30 – How to find Dr. Stifelman & closing advice

UVA School of Nursing scientist Randy Jones will discuss a decision tool he developed to help prostate cancer patients make treatment choices. Created with support from a $2.2 million National Institutes of Health grant, the tool is a valuable guide for patients when starting, stopping, or altering cancer treatment. Jones also talks about what conversations are important to have for patients like Biden and what advice he would have for patients beginning prostate cancer treatment.

September is Prostate Cancer Awareness month, with the disease now the most common cause of death from cancer for men in Australia. Advocacy groups are pushing for greater awareness and regular testing for all men in the country, including those from a multicultural background. - Сентябрь — месяц осведомлённости о раке простаты. Это заболевание в настоящее время является самой распространённой причиной смерти от рака среди мужчин в Австралии.

~Chat opens 1 hour before stream~Here is the link to the Williams Waiver https://www.hillandponton.com/wp-content/uploads/2025/05/Waiver-example.pdfVA Disability Calculator is here https://www.hillandponton.com/va-disability-calculator/Struggling to get the benefits you know you deserve? Get a free case evaluation now! - https://www.hillandponton.com/free-case-evaluation?utm_source=youtube&utm_medium=organic-video&utm_campaign=description&utm_id=Livestream+ShowJoin in our Live VA Disability Q&A Session in which we answer your questions live. We can't get to every single question so we will answer them as they come in. If you have any questions about the VA Disability Benefits process you can ask the question in the comment section when we go live and a little earlier. We are nationwide VA Accredited Disability Lawyers. We can't wait to answer your questions!For a FREE Case Evaluation go here: https://www.hillandponton.com/free-ca...Visit our website at https://www.hillandponton.com/?utm_so...Like us on Facebook at www.facebook.com/HillandPontonFor questions please email us at Info@hillandponton.comSpeakers: Attorney Carol PontonSenior Appellate Counsel Kerry BakerThe content of this YouTube channel is provided for informational purposes only and is not intended to constitute legal advice. You should not rely upon any information contained on this YouTube channel for legal advice. Viewing this YouTube channel is not intended to and shall not create an attorney-client relationship between you and Hill and Ponton, PA. Messages or other forms of communication that you transmit to this YouTube channel will not create an attorney-client relationship and thus information contained in such communications may not be protected as privileged. Hill and Ponton, PA does not make any representation, warranty, or guarantee about the accuracy of the information contained in this YouTube channel or in links to other YouTube channels or websites. This YouTube channel is provided "as is," does not represent that any outcome or result from the viewing of this channel. Your use viewing of this YouTube channel is at your own risk. You enjoy this YouTube channel and its contents only for personal, non-commercial purposes. Neither Hill and Ponton, PA, nor anyone acting on their behalf, will be liable under any circumstances for damages of any kind.

Gert Attard joins the show to discuss his recent Cell publication looking at tumor transcriptome-wide expression classifiers in advanced prostate cancer.

Prostate cancer is one of the most common types of cancer. There are numerous choices for patients. Radiation is one route and now some patients at The University of Kansas Cancer Center can undergo all treatments in just one week.

Treating prostate cancer is challenging, but help may be on the way. Joshi Alumkal, Wicha family professor of oncology at the University of Michigan Rogel Cancer Center, explores how. Alumkal spent most of his childhood and early adulthood in Texas. He graduated summa cum laude from the University of Texas with a bachelor's in biology. […]

There is a new treatment option available now that can precisely target prostate lesions with electrical pulses, while helping preserve sexual function and urinary control. Whether you or a loved one has prostate disease, or you are a urologist considering this technology for your practice, you will not want to miss today's discussion on this innovative new option. September is Prostate Cancer Awareness Month, so we have a special episode today to kick it off. We are excited to welcome the distinguished urologist, Dr. Spencer Krane, to the Prostate Health Podcast. Dr. Krane is the Chief of Urology at the US Department of Veterans Affairs in New Orleans, Louisiana. He specializes in personalized medicine for patients with urologic malignancies, aiming to use new biomarkers, genomic classifications, epigenetic signatures, and advanced imaging modalities, including MRI-guided prostate biopsies, to offer his patients individualized care that improves cancer outcomes while minimizing therapy side effects. Dr. Krane has published extensively in urologic journals, and his work was selected to provide guidelines for urologic care. He has 50 peer-reviewed articles in national and international journals and has presented his work internationally, from Chile and Rome to Taiwan, as well as across the United States. We are excited to welcome him today to share his experience with the innovative new NanoKnife system as a treatment option for men with prostate tumors.  It is exciting to see ongoing innovation in the technology we have available for men with prostate tumors. For the appropriate candidates, this minimally invasive option offers precise targeting of the lesion while helping preserve both sexual function and urinary control.  Pertinent disclosure for today's episode – Dr. Krane is a paid consultant for AngioDynamics, Inc., which manufactures and sells the NanoKnife System. The views, information, and opinions expressed in this podcast are solely those of Dr. Krane, and does not necessarily represent those of AngioDynamics, Inc., its affiliates, or subsidiaries.  Show Highlights: Dr. Krane reviews the concept of targeted focal therapy and explains what  the NanoKnife system is Who is an ideal candidate for irreversible electroporation with the NanoKnife system? The advantages and features of the NanoKnife system   Does prostate size or shape limit the candidacy for IRE with the NanoKnife system? Would prostate anatomies on the MRI or biopsy exclude a patient from NanoKnife therapy? Dr. Krane explains how long it takes to resolve the initial decrease in sexual ability after NanoKnife therapy.   Why many patients experience improved urinary function in the long term after having NanoKnife therapy Dr. Krane clarifies the time it takes to resolve the initial decrease in sexual ability after being treated with NanoKnife therapy.   Links:  Follow Dr. Pohlman on Twitter and Instagram - @gpohlmanmd.  Get your free What To Expect Guide (or find the link on our podcast website)   Join our Facebook group  Follow Dr. Pohlman on X and Instagram  Sign up for the Prostate Health Academy   You can access Dr. Pohlman's free mini-webinar, where he discusses his top three tips to promote men's prostate health, longevity, and quality of life here.  

At Sarasota Memorial, the multi-disciplinary cancer care team provides prostate screening and diagnostic biopsy services, along with comprehensive care. Kunal Saigal, MD, Medical Director of Radiation Oncology at the Brian D. Jellison Cancer Institute, discusses the latest advancements in prostate cancer treatment, including the use of Pluvicto.You can also watch the video recording on our Vimeo channel here.For more health tips & news you can use from experts you trust, sign up for Sarasota Memorial's monthly digital newsletter, Healthe-Matters.

This week on Health Matters, Courtney talks with urologic oncologist Dr. Michael Feuerstein of Columbia and NewYork-Presbyterian The One, a new center for advanced care in Westchester, to discuss the importance of screening for prostate cancer. Dr. Feuerstein explains how blood tests work to detect prostate cancer, explores the latest advancements in treatment, and debunks common myths and misunderstandings about prostate health. ___Dr. Michael Feuerstein, MD, MPH, is the chief of urology at NewYork-Presbyterian Westchester and assistant professor in the Department of Urology at Columbia University Vagelos College of Physicians and Surgeons. Dr. Feuerstein is a board-certified urologist with over ten years of experience, specializing in minimally-invasive surgery for prostate, kidney, and bladder cancer. He received his medical degree and completed his urology residency training at Albany Medical Center. He completed a two-year fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center and received a master's degree in public health at the Columbia Mailman School of Public Health. Dr. Feuerstein's research focuses on improving quality of care and quality of life for patients diagnosed with urologic cancers. Dr. Feuerstein provides care at NewYork-Presbyterian The One, a state-of-the-art center for advanced care with doctors from Columbia in Westchester. The facility offers adult and pediatric care spanning more than 90 specialties and subspecialties, so patients can find the care they and their families need in one convenient location.___Health Matters is your weekly dose of health and wellness information, from the leading experts. Join host Courtney Allison to get news you can use in your own life. New episodes drop each Wednesday.If you are looking for practical health tips and trustworthy information from world-class doctors and medical experts you will enjoy listening to Health Matters. Health Matters was created to share stories of science, care, and wellness that are happening every day at NewYork-Presbyterian, one of the nation's most comprehensive, integrated academic healthcare systems. In keeping with NewYork-Presbyterian's long legacy of medical breakthroughs and innovation, Health Matters features the latest news, insights, and health tips from our trusted experts; inspiring first-hand accounts from patients and caregivers; and updates on the latest research and innovations in patient care, all in collaboration with our renowned medical schools, Columbia and Weill Cornell Medicine.To learn more visit: https://healthmatters.nyp.org

Welcome to another powerful episode of Navigating Cancer TOGETHER, hosted by Talaya Dendy.In this episode, we shine a spotlight on prostate cancer awareness, the critical issue of health disparities, and the vital importance of open conversations within the Black and African American community. Talaya is joined by a remarkable guest, Christopher Shaddock, a veteran and prostate cancer survivor who shares his powerful personal journey. From his unique experience living in Iceland to his candid discussion about the emotional and physical impacts of his diagnosis, Christopher's story is one of determination, advocacy, and hope.This episode is a must-listen for men, caregivers, and advocates who want to understand the unique challenges of a prostate cancer diagnosis and the power of sharing one's story and creating a domino effect.✨Highlights from the show:3:12 Christopher shares his unique experience living in Iceland9:49 Christopher's prostate cancer diagnosis story10:55 The emotional impact of diagnosis and treatment16:39 Side effects of prostate cancer treatment: what men should know24:34 Addressing health disparities and barriers for African American men30:25 The importance of support groups and advocacy32:23 The “domino effect” of sharing your story and inspiring othersTranscript: https://bit.ly/podscript171ResourcesThe Silent Killer - https://www.silentkillerdoc.comThe Ties That Bind - https://www.bluechildentertainment.com/the-ties-that-bind-crowdfundingZero Prostate Cancer - https://zerocancer.org/black-menRespond Study - https://www.respondstudy.org

What if prostate cancer treatment weren't months of daily radiation—but five ultra-precise sessions guided in real time by MRI? Today, Dr. Michael J. Zelefsky (Professor of Radiation Oncology, NYU Grossman School of Medicine) explains how MRI-LINAC and adaptive planning are redefining accuracy, reducing side effects, and personalizing care. A pioneer behind IMRT and image-guided radiotherapy, Dr. Zelefsky breaks down SBRT vs. IMRT, protons vs. photons, HDR brachytherapy, when to add hormone therapy, and how genomics + AI are shaping what's next.In this conversation, Dr. Zelefsky charts the evolution from long-course radiation to short-course SBRT with outcomes comparable to 7–9 week regimens—thanks to precision imaging and planning. He clarifies where IMRT ends and SBRT begins, why protons haven't shown superiority over photons in prostate cancer, and where HDR brachytherapy (Ir-192) shines—especially as a boost in higher-risk disease. We dig into dose equivalence (why 5×8 Gy can match ~80–90 Gy long-course), risk-based treatment + ADT duration, and how Decipher/Artera scores can refine decisions. Most exciting: MRI-LINAC with continuous motion monitoring keeps the prostate in a virtual “bullseye,” enabling whole-gland treatment with focal boosts today—and potentially true focal therapy tomorrow as biologic imaging and AI mature.Time-Stamped Highlights00:00 – Welcome 02:00 – Why Dr. Zelefsky's work is so respected; career arc and impact04:00 – What changed: CT/MRI planning → 3D-CRT → IMRT → SBRT12:45 – IMRT vs. SBRT: definitions, session counts, who gets what19:10 – Energy sources overview: photons, protons, brachytherapy20:30 – Protons vs. photons: evidence, indications, cost, access24:00 – HDR brachytherapy (Ir-192) as a temporary “in-and-out” boost28:00 – Dose logic: why 5×8 Gy (~40 Gy) ≈ long-course 80–90 Gy29:30 – Risk groups (low/intermediate/high) and when ADT is crucial33:00 – ADT durations (6–36 months): what trials actually showed37:00 – Genomics (Decipher/Artera): resolving risk discrepancies39:00 – What MRI-LINAC adds: real-time adaptive planning43:00 – Continuous Motion Monitoring (CMM): beam stops if target moves47:00 – Treat whole gland + boost the DIL (FLAME study approach)49:00 – Toward focal therapy with better biologic imaging + AI54:00 – How to choose: values, side-effects, lifestyle, comorbidities01:01:00 – Final guidance: don't be overwhelmed—multiple good option

In this episode, we will talk with Dr. Okey Enyia, a health policy executive, government relations leader, and scholar-activist whose work sits at the intersection of public health, advocacy, and equity. He is the author of his second forthcoming book The John Henry Health Equity Playbook: A Four-Year Policy Agenda for Black Men, which lays out a bold roadmap to improve health outcomes, strengthen families, and transform systems of care.

In this program: ALC feature about Prostate Cancer, Oliver Slewa talking about privacy awareness and in Australia explained: How to deal when confronted with wildlife in Australia

Prostate cancer may sound daunting, but the reality around its mortality risk can be surprisingly different from what most believe. In this episode, Dr. Stephen Petteruti takes a bold stance against the one-size-fits-all approach to prostate cancer treatment. Referencing pivotal studies like the Pivot and ProtecT trials, he shows that conventional treatments such as prostate removal, radiation, and biopsies often fail to improve longevity and in some cases, may cause more harm than good. The real threats to life? Heart disease, infections, and even treatment-induced complications.Dr. Stephen invites listeners to question the status quo and broaden their perspective. He offers strategic alternatives, including lifestyle changes and a focus on overall health, rather than just the prostate.Tune into the full episode of The Surprising Truth About Prostate Cancer and Mortality.Enjoy the podcast? Subscribe and leave a 5-star review. Dr. Stephen Petteruti is a leading Functional Medicine Physician dedicated to enhancing vitality by addressing health at a cellular level. Combining the best of conventional medicine with advancements in cellular biology, he offers a patient-centered approach through his practice, Intellectual Medicine 120. A seasoned speaker and educator, he has lectured at prestigious conferences like A4M and ACAM, sharing his expertise on anti-aging. His innovative methods include concierge medicine and non-invasive anti-aging treatments, empowering patients to live longer, healthier lives.Website: www.intellectualmedicine.com Website: https://www.theprostateprotocol.com/ YouTube: https://www.youtube.com/@intellectualmedicine LinkedIn: https://www.linkedin.com/in/drstephenpetteruti/ Instagram: instagram.com/intellectualmedine Consultation: https://www.theprostateprotocol.com/book-a-consultation Store: https://www.theprostateprotocol.com/store Community: https://www.theprostateprotocol.com/products/communities/v2/fightcancerlikeaman/home    Disclaimer:  The content presented in this video reflects the opinions and clinical experience of Dr. Stephen Petteruti and is intended for informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional diagnosis, treatment, or guidance from your personal healthcare provider. Always consult your physician or qualified healthcare professional before making any changes to your health regimen or treatment plan.Produced by https://www.BroadcastYourAuthority.com 

Prostate cancer is the most common cancer diagnosed in men and the five year survival rate is 97%.

NBC News Senior Business Analyst Stephanie Ruhle shares tips on bouncing back from summer spending. Also, an exclusive interview with Montell Jordan on Prostate Cancer Awareness Month and his journey following his diagnosis last year. Plus, bestselling author Xochitl Gonzalez shares the best new book releases this month. 

Two-time Busch Series champion Randy LaJoie was diagnosed with prostate cancer in July, and he agreed to sit down with host Rick Houston last week to tell his story. Following the interview with Randy, Rick and co-host Steve Waid respond with some thoughts of their own and then close the episode with a conversation with Deb Williams, former editor of Winston Cup Scene and the recently announced 2026 recipient of the Squier-Hall Award for NASCAR Media Excellence. NOTE: This show is not associated in any way with American City Business Journals, owner of the Scene brand. Be sure to check out the latest and greatest stories from the world of NASCAR at dailydownforce.com! Interested in The Scene Vault Podcast T-shirts? Check out thescenevault.com and click on SHOP to see what we have available! Please consider supporting this show via: patreon.com/thescenevaultpodcast paypal.me/thescenevaultpodcast venmo.com/thescenevaultpodcast Learn more about your ad choices. Visit megaphone.fm/adchoices